The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling.
The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...